Restricted accessResearch articleFirst published online 2023-3
The Impact of Telemedicine-Augmented Integrated Personalized Diabetes Management on Glycemic Control in Adults With Diabetes Mellitus During the COVID-19 Pandemic: A Retrospective Study
de KreutzenbergSV. Telemedicine for the clinical management of diabetes: implications and considerations after COVID-19 experience. High Blood Press Cardiovasc Prev. 2022;29(4):319-326.
2.
CrossenSSBruggemanBSHallerMJRaymondJK. Challenges and opportunities in using telehealth for diabetes care. Diabetes Spectr. 2022;35(1):33-42.
3.
LeeSWHChanCKYChuaSSChaiyakunaprukN. Comparative effectiveness of telemedicine strategies on type 2 diabetes management: a systematic review and network meta-analysis. Sci Rep. 2017;7(1):12680.
4.
LeeSWHOoiLLaiYK. Telemedicine for the management of glycemic control and clinical outcomes of Type 1 diabetes mellitus: a systematic review and meta-analysis of randomized controlled studies. Front Pharmacol. 2017;8:330.
5.
KulzerBDaenschelWDaenschelI, et al. Integrated personalized diabetes management improves glycemic control in patients with insulin-treated type 2 diabetes: results of the PDM-ProValue study program. Diabetes Res Clin Pract. 2018;144:200-212.
6.
PorntharukchareonTWorawichawongSTawinpraiK. Telehealth for diabetes care during coronavirus disease 2019 pandemic. Asia Pac J Public Health. 2022;34(4):459-462.
7.
AreevutCSakmanaritJTachanivateP, et al. Noninferiority of telemedicine delivered compared with in-person Diabetes Self-Management Education and Support (DSMES) during Covid-19 pandemic in Thailand. Asia Pac J Public Health. 2022;34(8):799-803.
8.
DrazninBArodaVRBakrisG, et al. 6. Glycemic targets:Standards of Medical Care in Diabetes—2022. Diabetes Care. 2022;45(suppl 1):S83-S96.
9.
LeRoithDBiesselsGJBraithwaiteSS, et al. Treatment of diabetes in older adults: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2019;104(5):1520-1574.
